MMED (Minimed Group) Notes Receivable: $0 Mil (As of Jan. 2026)


MMED Minimed Group Inc MMED
15 GF Score
Price $14.28
! 1 Warning Sign
View Full Analysis

What is Minimed Group Notes Receivable?

Minimed Group MMED +0.14% 15 Notes Receivable is $0 Mil as of Jan. 2026. GuruFocus rates MMED with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

Minimed Group's Notes Receivable for the quarter that ended in Jan. 2026 was $0 Mil.

Minimed Group Notes Receivable Historical Data

* Premium members only.

The historical data trend for Minimed Group's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minimed Group Notes Receivable Chart

Minimed Group Annual Data
Trend Apr23 Apr24 Apr25
Notes Receivable
0.00 0.00 0.00

Minimed Group Quarterly Data
Apr24 Jan25 Apr25 Oct25 Jan26
Notes Receivable 0.00 0.00 0.00 0.00 0.00
MMED
15GF Score
Minimed Group Inc MMED
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Minimed Group Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0 Mil mean?
Minimed Group (MMED) has a Notes Receivable of $0 Mil as of Jan. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Minimed Group and its competitors.
Is Minimed Group's Notes Receivable too high?
Minimed Group's current Notes Receivable is $0 Mil. Overall, Minimed Group has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Minimed Group's Notes Receivable compare to ICUI and WRBY?
Minimed Group's Notes Receivable of $0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Minimed Group and its competitors. Minimed Group's current Notes Receivable is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minimed Group stock overvalued right now?
Minimed Group (MMED) has a current Notes Receivable of $0 Mil. The current Notes Receivable is $0 Mil. Minimed Group's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Minimed Group (MMED), the current Notes Receivable is $0 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minimed Group Business Description

Other Exchanges B8S:Germany
Address 18000 Devonshire Street, Northridge, CA, USA, 91325
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
15GF Score

Get the complete analysis for MMED

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.28
Price